Saladax, Transmedic Partner to Distribute Oncology Dosing Assays in Singapore, Hong Kong | GenomeWeb

NEW YORK (GenomeWeb News) – Saladax on Friday said that it has reached a distribution deal with Transmedic covering Saladax's MyCare oncology therapeutic dose management assays in Singapore and Hong Kong.

The MyCare assays include My5-FU, MyPaclitaxel, and MyDocetaxel products, which guide physicians in maintaining an optimal therapeutic range during the period of treatment, the Bethlehem, Penn.-based firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.